Answer
Fidaxomicin should be used cautiously in patients with severe renal impairment or moderate to severe hepatic impairment because clinical data in these populations are limited.
Sources for this answer
- Fidaxomicin Tillotts 200mg film-coated tabletsTillotts Pharma UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked